Skip to main content
Fig. 2 | Breast Cancer Research

Fig. 2

From: Evaluation of α-tubulin, detyrosinated α-tubulin, and vimentin in CTCs: identification of the interaction between CTCs and blood cells through cytoskeletal elements

Fig. 2

Quantification of cytokeratin (CK), α-tubulin (TUB), detyrosinated α-tubulin (GLU), and vimentin (VIM) in patients with early and metastatic breast cancer. a Percentage of the corresponding circulating tumor cell (CTC) phenotypes in patients’ blood. Each patient was considered as positive for a distinct phenotype if she harvested at least on CTC in her blood with this phenotype. b Quantification of TUB, GLU, and VIM intensity in CTCs derived from patients with early and metastatic breast cancer. c Quantification of CK/TUB, CK/GLU, and CK/VIM ratios in CTCs derived from patients with early and metastatic breast cancer. d Patient CTCs stained with pancytokeratin (A45-B/B3, green) antibody and CD45 (hematopoietic cell marker, blue) antibody

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us